Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Standard Biotools (LAB) Equity Ratio (2016 - 2026)

Standard Biotools has reported Equity Ratio over the past 16 years, most recently at 0.75 for Q4 2025.

  • Quarterly Equity Ratio fell 2.99% to 0.75 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.75 through Dec 2025, down 2.99% year-over-year, with the annual reading at 0.75 for FY2025, 2.99% down from the prior year.
  • Equity Ratio was 0.75 for Q4 2025 at Standard Biotools, up from 0.74 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.78 in Q1 2025 and troughed at 0.46 in Q4 2023.
  • The 5-year median for Equity Ratio is 0.37 (2021), against an average of 0.28.
  • Year-over-year, Equity Ratio crashed 421.47% in 2023 and then skyrocketed 383.99% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.34 in 2021, then tumbled by 160.73% to 0.21 in 2022, then plummeted by 119.56% to 0.46 in 2023, then soared by 268.1% to 0.77 in 2024, then dropped by 2.99% to 0.75 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Equity Ratio are 0.75 (Q4 2025), 0.74 (Q3 2025), and 0.76 (Q2 2025).